Spanish hospitals are exploring early type 1 diabetes screening, with first-degree relatives identified as the clearest group for targeted testing. Blood tests for autoantibodies can detect the disease before symptoms appear. A pilot programme at Madrid’s La Paz University Hospital has been running for about a year.
Specialists describe the disease as a four-stage process. As it develops, beta cells in the pancreas are progressively destroyed. Identifying the condition early can avert emergency diagnoses and give families time to prepare.
Figures presented at a specialists’ meeting put the number of people with type 1 diabetes in Spain at an estimated 100,000 to 200,000. Infosalus reported that diabetic ketoacidosis is the initial presentation in more than one-third of children diagnosed in the country. Early detection and follow-up are intended to give families time to learn about the disease before it reaches clinical onset.
First-degree relatives are the clearest group for targeted screening because their risk is higher than that of people without a family history. Noemí González, the hospital’s deputy medical director and head of diabetes, said the pilot at La Paz had been running for about a year. Luis Castaño, a paediatric endocrinologist at Cruces University Hospital in Bilbao, has also noted that type 1 diabetes can be detected before symptoms appear.
Turning hospital experience into routine care across the Sistema Nacional de Salud remains an open question. Specialists have linked the development of screening programmes to scientific consensus and the recently published Proceso Asistencial Integrado, or PAI, an integrated care pathway. A sustainable model would need to coordinate referrals and confirmation, while setting out how patients are followed up. Specialists also need to consider how to reach people with no known affected relatives.
Those implementation questions were at the centre of «A tempo: Conversaciones de dos a tres», a meeting organised by Levin with support from Sanofi. Servimedia reported that Belén Gómez del Pino, a journalist specialising in medical information, moderated the discussion on bringing early detection into clinical practice and coordinating care sustainably.
González has described targeted programmes for people at increased risk as a way to lay the foundations for earlier detection. Giving families time to learn about the condition and prepare could change how they experience diagnosis, so they do not first encounter the disease in an emergency.
Recent coverage of arrests near Madrid's Sol concerned a separate public-affairs issue. The diabetes meeting focused on how hospitals and the national health system can handle early detection.
